ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,740 | -33.9% | 60,400 | 0.0% | 0.00% | – |
| Q2 2023 | $626,348 | +28.2% | 60,400 | 0.0% | 0.00% | – |
| Q1 2023 | $488,636 | -48.6% | 60,400 | 0.0% | 0.00% | – |
| Q4 2022 | $951,300 | +31.0% | 60,400 | +31.0% | 0.00% | – |
| Q3 2022 | $726,000 | +12.7% | 46,100 | 0.0% | 0.00% | – |
| Q2 2022 | $644,000 | -10.7% | 46,100 | +10.3% | 0.00% | – |
| Q1 2022 | $721,000 | +52.1% | 41,800 | +28.2% | 0.00% | – |
| Q4 2021 | $474,000 | -5.2% | 32,600 | +17.3% | 0.00% | – |
| Q3 2021 | $500,000 | +2.5% | 27,800 | 0.0% | 0.00% | – |
| Q2 2021 | $488,000 | +756.1% | 27,800 | -49.6% | 0.00% | – |
| Q1 2020 | $57,000 | -45.2% | 55,200 | 0.0% | 0.00% | – |
| Q4 2019 | $104,000 | +73.3% | 55,200 | 0.0% | 0.00% | – |
| Q3 2019 | $60,000 | -50.4% | 55,200 | 0.0% | 0.00% | – |
| Q2 2019 | $121,000 | -57.5% | 55,200 | +16.2% | 0.00% | – |
| Q1 2019 | $285,000 | -2.4% | 47,500 | +20.3% | 0.00% | – |
| Q4 2018 | $292,000 | -35.0% | 39,500 | +27.8% | 0.00% | – |
| Q3 2018 | $449,000 | -21.9% | 30,900 | +7.3% | 0.00% | – |
| Q2 2018 | $575,000 | +39.2% | 28,800 | +22.0% | 0.00% | – |
| Q1 2018 | $413,000 | -14.1% | 23,600 | +21.0% | 0.00% | – |
| Q4 2017 | $481,000 | -4.4% | 19,500 | 0.0% | 0.00% | – |
| Q3 2017 | $503,000 | -4.9% | 19,500 | 0.0% | 0.00% | – |
| Q2 2017 | $529,000 | +91.0% | 19,500 | +109.7% | 0.00% | – |
| Q1 2017 | $277,000 | +35.8% | 9,300 | +24.0% | 0.00% | – |
| Q4 2016 | $204,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |